Evidence map›Paper›PMID 40456181›Full record

ArticleEmerging infectious diseases2025

Increasing Predominance of Norovirus GII.17 over GII.4, United States, 2022-2025.

Leslie Barclay, Jan Vinjé

Abstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Global trends in norovirus genotype distribution among medically attended children with acute gastroenteritis, 2020-2025.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2026
    Article
  8. [Noroviruses in 2026: red flags and outbreak management in acute care].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026
    Article
  9. Article
  10. Article
  11. Molecular genetic characterisation of norovirus GII.17 strains circulating in South Korea in 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Recovery of infectious recombinant human norovirus using zebrafish embryos.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leslie Barclay
Jan Vinjé

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Norovirus GII.17 outbreaks in the United States increased from <10% during the 2022-23 season to 75% during the 2024-25 season, surpassing the number of GII.4 outbreaks. The norovirus season also started earlier in 2024-25 than in previous seasons. Continued norovirus surveillance is needed to detect and monitor emerging strains.

Indexed as

Caliciviridae InfectionsGastroenteritisNorovirusDisease OutbreaksGenotypeHistory, 21st CenturyHumansPhylogenySeasonsUnited Statesenteric infectionsGII.17GII.4norovirusUnited Statesviruses

Identifiers

PMID40456181
PMCPMC12205451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.